VON-WILLEBRAND DISEASE IN CHILDHOOD

被引:14
|
作者
SCHNEPPENHEIM, R
THOMAS, KB
SUTOR, AH
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL, CHILDRENS HOSP, KIEL, GERMANY
[2] UNIV FREIBURG, CHILDRENS HOSP, FREIBURG, GERMANY
关键词
VON WILLEBRAND DISEASE; BLEEDING; VON WILLEBRAND FACTOR; CHILDREN; NEWBORN;
D O I
10.1055/s-2007-1000648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand disease (vWD), a disorder of primary hemostasis, represents the most frequently inherited bleeding diathesis. It is caused by a quantitative reduction or a qualitative abnormality, or both, of von Willebrand factor (VWF), a glycoprotein normally found in plasma, endothelial cells, subendothelial cell space, megakaryocytes and platelets. Patients with VWD represent a heterogeneous group with different phenotypes and with clinical symptoms that vary in severity. Many of the described types and subtypes of vWD are caused by mutations and aberrations of the vWF gene. The aim of this article is to highlight the impact of gene analysis on the current knowledge of the inheritance of VWD as well as on the structure-function relationship of VWF, and to focus on the available diagnostic laboratory tests and treatment options for patients with VWD, especially in childhood.
引用
收藏
页码:261 / 275
页数:15
相关论文
共 50 条
  • [21] Utility of thromboelastography for the diagnosis of von Willebrand disease
    Regling, Katherine
    Kakulavarapu, Srikruthi
    Thomas, Ronald
    Hollon, Wendy
    Chitlur, Meera B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [22] Advances in the diagnosis and management of von Willebrand disease
    Franchini, Massimo
    HEMATOLOGY, 2006, 11 (04) : 219 - 225
  • [23] Vonicog alfa for the treatment of von Willebrand disease
    Castaman, Giancarlo
    Linari, Silvia
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (05): : 549 - 554
  • [24] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    HAEMOPHILIA, 2022, 28 : 11 - 17
  • [25] ARG578GLN MUTATIONS IN THE VON-WILLEBRAND-FACTOR GENE IN 3 UNRELATED CASES OF TYPE-IIB VON-WILLEBRAND DISEASE
    PIAO, YC
    LAVERGNE, JM
    BOYERNEUMANN, C
    SCHANDELONG, A
    ALESSI, MC
    MEYER, D
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) : 787 - 789
  • [26] Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease
    Rydz, N.
    Grabell, J.
    Lillicrap, D.
    James, P. D.
    HAEMOPHILIA, 2015, 21 (05) : 636 - 641
  • [27] Prophylaxis in von Willebrand disease
    Massimo Franchini
    Giovanni Targher
    Giuseppe Lippi
    Annals of Hematology, 2007, 86 : 699 - 704
  • [28] Prophylaxis in von Willebrand disease
    Franchini, Massimo
    Targher, Giovanni
    Lippi, Giuseppe
    ANNALS OF HEMATOLOGY, 2007, 86 (10) : 699 - 704
  • [29] Diagnosis of von Willebrand disease
    Ingerslev, J
    Gürsel, T
    HAEMOPHILIA, 1999, 5 : 50 - 56
  • [30] Von Willebrand Disease: An Overview
    Bharati, K. Pavani
    Prashanth, U. Ram
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 73 (01) : 7 - 16